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Abstract 28 
The influence of different substrates and the effect of pH regulation during enzymatic hydrolysis of 29 
whey protein on glucose-stimulated insulin secretion by BRIN-BD11 pancreatic beta cells were studied. 30 
No significant differences (P ≥ 0.05) were detected in terms of glucose-stimulated insulin secretion by 31 
BRIN-BD11 pancreatic beta cells exposed to hydrolysates obtained with two different whey protein 32 
substrates WPH1 (5.62 ± 0.42 ng mg
-1
 protein) or WPH2 (5.79 ± 0.35 ng mg
-1
 protein). The whey pro-33 
tein hydrolysate (WPH3) obtained without pH regulation during hydrolysis, had a significantly lower 34 
insulinotropic potential (4.10 ± 0.55 ng mg
-1
 protein) in BRIN-BD11 cells than the WPH1 hydrolysate 35 
which was manufactured with pH regulation. Fractionation of WPH1 was carried out to enrich bioactive 36 
peptides. Comparing the different fractionation techniques studied (solid-phase extraction and semi-37 
preparative reversed phase-high performance liquid chromatography),), the most potent insulinotropic 38 
fraction was enriched in free amino acids and contained relatively hydrophilic peptides. This indicates 39 
that amino acids and hydrophilic peptides may be involved in the insulinotropic effect of WPH1. 40 
41 
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1. Introduction 42 
Consumption of dairy products and particularly low-fat dairy products has been linked with a reduc-43 
tion in the risk of type 2 diabetes (Choi, Willett, Stampfer, Rimm, & Hu, 2005; Tremblay & Gilbert, 44 
2009). The beneficial role of milk proteins, milk-derived peptides and associated amino acids in the 45 
regulation of postprandial glycaemia and insulin secretion in normoglycaemic and type 2 diabetic sub-46 
jects has been demonstrated (Akhavan, Luhovyy, Brown, Cho, & Anderson, 2010; Frid, Nilsson, Holst, 47 
& Björck, 2005; Geerts et al., 2011; Manders et al., 2006a; Manders et al., 2006b). In vitro studies using 48 
pancreatic beta-cell lines or primary islet cells have shown significant acute insulinotropic effects of dif-49 
ferent amino acid residues (Ala, Leu, Arg and Gln) (Dixon, Nolan, McClenaghan, Flatt, & Newsholme, 50 
2003; Newsholme, Brennan, & Bender, 2006) and incretin hormones (gastro-inhibitory polypeptide-GIP 51 
and GIP analogues) (Gault, Flatt, & O’Harte, 2003; Gault, O’Harte, & Flatt, 2003). Ingestion of amino 52 
acids (Leu, Arg, Ile, Phe and Ala) or milk-derived peptides with (Geerts et al., 2011; Luhovyy, 53 
Akhavan, & Anderson, 2007; Manders et al., 2006a; Manders et al., 2006b) or without carbohydrates 54 
(Akhavan et al., 2010; Morifuji et al., 2010; Power, Hallihan, & Jakeman, 2009) has been shown to in-55 
crease insulin secretion in humans. Intake of hydrolysed milk proteins generally results in higher in vivo 56 
insulinotropic effects compared to unhydrolysed proteins (Morifuji et al., 2010; Power et al., 2009). 57 
However, the mechanisms governing the insulinotropic properties of milk protein hydrolysates are not 58 
completely understood. This is illustrated by differences observed in the outcomes of human trials 59 
where subjects were administered whey protein hydrolysates. In the study of Akhavan et al. (2010) no 60 
effect on post-meal blood glucose was observed following ingestion of a commercial whey protein hy-61 
drolysate. In other studies, differences in plasma amino acid composition were seen. Plasma branched 62 
chain amino acid (BCAA) levels were increased after ingestion of a whey protein hydrolysate compared 63 
to unhydrolysed proteins (Morifuji et al., 2010). In contrast, no difference in plasma BCAA was found 64 
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between ingestion of a whey protein hydrolysate and the unhydrolysed protein (Power et al., 2009). It 65 
has been suggested that the differences observed between various studies may arise from the protein 66 
source and the extent of protein breakdown (Morifuji et al., 2010). To date, most of the hydrolysates 67 
which have been used to stimulate insulin secretion in vivo have not been characterized in terms of pep-68 
tide composition thereby making interpretation of results based on peptide bioactive properties prob-69 
lematic. 70 
In a previous study, we developed a whey protein hydrolysate (WPH1) which promoted a strong 71 
acute insulin secretion response in the presence of glucose from a clonal rat pancreatic beta cell line 72 
(BRIN-BD11) (Gaudel et al., 2013). This hydrolysate also increased insulin secretion in vivo when ad-73 
ministered by oral gavage for 8 weeks to ob/ob mice. This treatment resulted in a restoration of insulin 74 
secretion following glucose stimulation of the pancreatic islets isolated from ob/ob mice. Treatment 75 
with WPH also led to better glucose clearance after a glucose challenge (2 g kg
-1 
body weight) along 76 
with an overall decrease in basal plasma insulin in ob/ob mice. The peptides in WPH1 were fractionated 77 
on the basis of molecular mass differences, however, most of the ultrafiltration fractions generated 78 
(permeates and retentates) were insulinotropic when tested in vitro with BRIN-BD11 cells (Gaudel et 79 
al., 2013). 80 
A significant amount of data exists in relation to the insulinotropic properties of whey protein hy-81 
drolysates. However, little information appears in the literature dealing with fractionation of insulino-82 
tropic peptides from whey protein hydrolysates (Gaudel et al., 2013). The objective of this study was to 83 
determine the influence of two protein substrates and variation in the hydrolysis conditions (with/ with-84 
out pH control) on the insulinotropic activity of whey protein hydrolysates. Whey protein hydrolyates 85 
can be very complex mixtures of free amino acids and peptides, making it difficult to identify the origin 86 
of the bioactive components. Therefore, a second objective of this study was to characterise the role of 87 
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ultrafiltration, solid-phase extraction (SPE) using a reverse phase polymeric sorbent (Strata-X) and 88 
semi-preparative high pressure liquid chromatography (HPLC) in the enrichment of insulinotropic frac-89 
tions from an insulinotropic whey protein hydrolysate. 90 
2. Materials and methods 91 
2.1. Reagents 92 
Trifluoroacetic acid (TFA), activated carbon (AC), L-glutamine, and D-glucose were obtained from 93 
Sigma Aldrich (Dublin, Ireland). Hydrochloric acid (HCl), sodium hydroxide (NaOH), HPLC grade wa-94 
ter and acetonitrile (ACN) were from VWR (Dublin, Ireland). Roswell Park Memorial Institute (RPMI)  95 
1640 medium, foetal calf serum, antibiotics (penicillin and streptomycin) and Phosphate Buffer Saline 96 
(PBS) were obtained from Invitrogen (Carlsbad, CA, USA). Solid-phase extraction (SPE) Giga Tubes 97 
StrataX cartridges (33 µm, 85Å Polymeric RP 1 g, 12 mL tubes) were obtained from Phenomenex 98 
(Cheshire, UK). Whey protein substrates WP1 and WP2 were from Carbery Milk Products (Ballineen, 99 
Ireland). 100 
2.2. Hydrolysis of whey protein and physicochemical characterisation of the hydrolysates 101 
In order to study the influence of the starting substrate on insulinotropic properties, two different 102 
whey protein substrates WP1 (88.3 % (w/w) protein, 1 % (w/w) fat and 2.4 % (w/w) ash) and WP2 103 
(77.9% (w/w) protein, 7.4 % (w/w) fat and 2.8 % (w/w) ash) were hydrolysed. Hydrolysates were gen-104 
erated at pH 7.0, 50°C for 240 min using a pancreatic enzyme preparation as described by Nongonierma 105 
& FitzGerald (2012). WP1 and WP2 were used to produce hydrolysates WPH1 and WPH2, respective-106 
ly. A similar procedure as above was also used to hydrolyse WP1, except that NaOH was not added to 107 
control the pH during hydrolysis, this allowed generation of hydrolysate WPH3. The WPH1 hydrolysate 108 
was generated as two independent duplicates while WPH2 and WPH3 were generated once. Reproduci-109 
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ble results were obtained during duplicate generation of WPH1 in terms of its peptide composition and 110 
insulinotropic properties. For all three hydrolysates, the enzyme was inactivated by heating at 90°C for 111 
20 min, samples were subsequently freeze-dried (FreeZone 18L, Labconco, Kansas City, MO, USA) 112 
and stored at -20°C until utilisation. 113 
2.3. Fractionation of WPH1 114 
Different fractionation techniques were used to separate the peptides present in WPH1 as follows: 115 
Membrane processing of WPH1: WPH1 was fractionated using an ultrafiltration (UF) unit (Sar-116 
toflow Alpha, Sartorius, Göttingen, Germany) and a Minimate-TFF System (Pall, Port Washington, NY, 117 
USA). Fractionation was sequentially carried out using membranes having 5 and 2 kDa (stabilized cel-118 
lulose) and 0.65 kDa (polyethersulfone) molecular weight cut-off (MWCO) values. The six UF fractions 119 
(permeates and retentates) generated were freeze-dried and stored at -20°C until utilisation. 120 
Fractionation by solid-phase extraction: WPH1 was resuspended in HPLC grade water at a concen-121 
tration of 1 % (w/v) and applied on different adsorbents (Strata-X and AC). The first adsorbent used was 122 
a commercial SPE cartridge (Strata-X). The second adsorbent used was AC, which has previously been 123 
used for selective binding of hydrophobic peptides (Voirin, Letavernier, & Sebille, 1991). A custom-124 
made SPE cartridge containing AC was assembled as per Nongonierma and FitzGerald (2012). The SPE 125 
cartridges were connected to a vacuum (15 mmHg) manifold (Phenomenex) for extraction of different 126 
fractions. The procedure followed with both SPE cartridges was a modification of the technique de-127 
scribed by Herraiz and Casal (1995). A 40 mL aliquot of WPH1 (1 % (w/v)) was slowly applied at the 128 
top of the SPE cartridges to allow adsorption of the peptides. The SPE cartridges were then washed with 129 
HPLC grade water (10 mL) to remove any unbound material. Stepwise elution with different solutions 130 
(10 mL) of 5 to 50 % (v/v) ACN in water was then used to desorb peptides from the SPE cartridges. At 131 
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the end of the extraction procedure, the SPE cartridges were washed with 100 % ACN. The fractions 132 
obtained were dried in a solvent evaporator (Genevac, EZ-2 Plus, Ipswich, UK). 133 
Semi-preparative RP-HPLC: Fractionation of WPH1 was also carried out using semi-preparative RP-134 
HPLC (Waters). WPH1 was resuspended at 12 % (w/v) in HPLC grade water and 500 µL aliquots were 135 
injected on a C18 semi-preparative column (250 × 15mm I.D., 10 µm particle size, Phenomenex) at-136 
tached to a C18 guard column (Phenomenex). Mobile phase A was HPLC grade water, and mobile 137 
phase B was 100 % (v/v) ACN. The flow rate was set at 6 mL min
-1
 and separation of peptides was car-138 
ried out using the following linear gradient : 0-25 min: 100 % A; 25-80 min: 100-30 % A; 80-85 min: 139 
30-0 % A; 85-90 min 0 % A; 90-95 min: 0-100 % A; 95-100 min 100 % A. The absorbance of the elu-140 
ent was monitored at 214 nm. Fractions (56 x 9 mL) were collected using a fraction collector (Waters) 141 
during each run. The fractions were pooled into 10 fractions (F1 to F10) collected at 4.5, 10.5, 18.0, 142 
24.0, 34.5, 45.0, 54.0, 60.0, 80.0 and 84.0 min, respectively. The semi-preparative procedure was car-143 
ried out in triplicate and individual fractions from the 3 runs in turn were pooled. The different fractions 144 
were evaporated to dryness using in a solvent evaporator. 145 
2.4. Reverse-phase high performance liquid chromatography (RP-HPLC) and ultra-performance liquid 146 
chromatography (RP-UPLC) analysis of the hydrolysates 147 
Unhydrolysed whey proteins (WP1), hydrolysate (WPH1) and ultrafiltration fractions of WPH1 were 148 
analysed by RP-HPLC using a Waters (Dublin, Ireland) liquid chromatography system mounted with a 149 
250 x 4.6 mm I.D., 5.0 µm Jupiter C18 column coupled to a C18 guard column (4 x 3 mm I.D., Phe-150 
nomenex). Samples were resuspended at 0.8 % (w/v) in 0.1% TFA in HPLC water. Detection of pep-151 
tides and proteins was carried out at 214 nm. Separation was carried out as described in Spellman 152 
O’Cuinn & FitzGerald (2009). Whey protein substrates (WP1 and WP2), hydrolysates (WPH1, WPH2 153 
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and WPH3) and the SPE fractions were also analysed by reverse phase ultra-performance liquid chro-154 
matography (RP-UPLC) using an Acquity UPLC (Waters) as described by Nongonierma and FitzGerald 155 
(2012). Samples were resuspended at 0.5 % (w/v) in 0.1% TFA in HPLC water. 156 
 157 
2.5. Cell culture and measurement of acute insulin secretion 158 
Acute insulin secretion was measured according to Gaudel et al. (2013). Briefly, BRIN-BD11 cells 159 
were seeded at 1.5 x 10
5
 in 24-well plates in RPMI-1640 medium to adhere overnight. Medium was re-160 
moved and cells were washed with PBS before incubation in Krebs-Ringer bicarbonate buffer at pH 7.4 161 
containing 1.1 mM of D-glucose. After 40 min, the buffer was removed and replaced by a Krebs-Ringer 162 
bicarbonate buffer at pH 7.4 containing 16.7 mM of D-glucose and an aqueous solution of unhydrolysed 163 
whey protein substrates (WP1 and WP2), hydrolysates (WPH1, WPH2 and WPH3) or WPH1 fractions 164 
all at 1 mg mL
-1
. The blank for the assay consisted of Krebs-Ringer bicarbonate buffer at pH 7.4. The 165 
positive control was Krebs-Ringer bicarbonate buffer at pH 7.4 enriched with 16.7 mM of D-glucose 166 
containing 10 mM alanine. After 20 min incubation, the supernatant was removed and used to quantify 167 
insulin secretion using an ultrasensitive insulin enzyme linked immunosorbent assay (ELISA) kit 168 
(Mercodia, Uppsala, Sweden).  169 
2.6. Statistical analysis 170 
Means comparison was carried out with a one way ANOVA followed by a Student Newman-Keuls 171 
test using SPSS (version 9, SPSS Inc., Chicago, IL, USA) at a significance level P < 0.05. 172 
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3. Results 173 
3.1. Influence of the starting substrate and hydrolysis protocol on the physicochemical characteristics 174 
and in vitro insulinotropic properties of whey protein hydrolysates 175 
Hydrolysis of WP1 and WP2 was carried out with the same protocol with pH regulation at 7.0 to 176 
yield WPH1 and WPH2, respectively. The RP profiles of WP1 and WP2 (Supplementary data Fig. S1A 177 
and S1C, respectively) showed that both substrates contained the four major whey proteins (i.e. β-178 
lactoglobulin, α-lactalbumin, bovine serum albumin and caseinomacropeptide). The RP profiles of 179 
WPH1 (Supplementary data Fig. S1B) and WPH2 (Supplementary data Fig. S1D) differed with WPH2 180 
containing no residual intact α-lactalbumin and β-lactoglobulin in contrast to WPH1. These differences 181 
may arise from the fact that both substrates were injected at the same concentration on a weight basis. 182 
The lower protein content of WP2 (77.9 % (w/w)) compared to WP1 (88.3 % (w/w)) yielded lower in-183 
tensity protein peaks for WP2 compared to WP1. WP1 was hydrolysed using two different protocols. As 184 
outlined, WPH1 was generated under controlled pH (7.0) conditions while WPH3 was generated with-185 
out pH control during hydrolysis. The final pH of WPH3 was 6.2 after 240 min incubation. The RP-186 
UPLC profiles show that WP1 (Supplementary data Fig. S1A) was degraded over the course of hydroly-187 
sis, giving a large range of different peptides in WPH1 (Supplementary data Fig. S1B) and WPH3 (Sup-188 
plementary data Fig. S1E). Differences were evident in the RP profiles of both hydrolysates, lower in-189 
tensity peptide peaks were present in WPH3 compared to WPH1. In addition, WPH1 only contained 190 
trace amounts of the intact proteins (α-lactalbumin, β-lactoglobulin and caseinomacropeptide) whereas 191 
WPH3 contained distinct peaks corresponding to unhydrolysed caseinomacropeptide, α-lactalbumin and 192 
β-lactoglobulin. 193 
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The three hydrolysates WPH1 (WP1, pH control), WPH2 (WP2, pH control) and WPH3 (WP1, 194 
without pH control) were tested for their insulinotropic properties in the presence of glucose using 195 
BRIN-BD11 pancreatic beta cells. The level of acute insulin secretion by the three hydrolysates and the 196 
unhydrolysed whey protein substrates is given in Table 1. The insulin secretion values for the hydroly-197 
sates were significantly higher (P < 0.05) than for the unhydrolysed whey proteins. No significant dif-198 
ference (P ≥ 0.05) between WPH1 (5.62 ± 0.42 ng mg-1 protein) and WPH2 (5.79 ± 0.35 ng mg-1 pro-199 
tein) was seen in terms of insulin secretion. Insulin secretion induced by the addition of WPH3 (4.10 ± 200 
0.55 ng mg
-1
 protein) was significantly lower (P < 0.05) than that for WPH1 and WPH2. 201 
3.2. Fractionation of WPH1 on the basis of molecular mass and effect on in vitro insulin secretion 202 
UF of WPH1 was carried out using membranes having different MWCO values (5, 2 and 0.65 kDa) 203 
allowing generation of six different fractions. The RP-UPLC (Supplementary data Fig. S1A) and the 204 
RP-HPLC (Supplementary data Fig. S2A) profiles of WP1 were similar. As expected, under the separa-205 
tion conditions employed, better separation of β-lactoglobulin A and B was obtained in WP1 following 206 
RP-UPLC analysis. The RP-HPLC profiles of WP1 (Supplementary data Fig. S2A), WPH1 (Supple-207 
mentary data Fig. S2B) and the 2 kDa permeate of WPH1 (Supplementary data Fig. S2C) were com-208 
pared. The RP-HPLC profile of the 2 kDa permeate differed from that of WPH1, showing a less com-209 
plex peptide profile. The peptides eluting in the hydrophobic region of the RP-HPLC profiles (retention 210 
time > 30 min) were present at significantly lower levels in the 2 kDa permeate (Supplementary data 211 
Fig. S2C) compared to WPH1 (Supplementary data Fig. S2B). Some peptide peaks present in WPH1 212 
were not seen in the 2 kDa permeate, which corresponded to peptides which remained in the retentates 213 
at the different stages of the UF procedure (data not shown). As would be expected during enrichment 214 
of low molecular mass components during UF processing, some peaks were more abundant in the 2 kDa 215 
permeate compared to WPH1. Insulin secretion by BRIN-BD11 cells was stimulated by the 2 kDa per-216 
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meate showing similar (P ≥ 0.05) secretion to WPH1 (data not shown). Nevertheless, the RP-HPLC pro-217 
file of the 2 kDa permeate (Supplementary data Fig. S2C) was still relatively complex. Therefore, other 218 
fractionation techniques were used in order to enrich for the bioactive peptides in WPH1. This involved 219 
SPE with Strata-X (reverse phase polymeric sorbent) and AC cartridges, and semi-preparative RP-220 
HPLC. 221 
3.3. Fractionation of WPH1 via SPE 222 
SPE with Strata-X (SPE X) allowed generation of twelve fractions (Table 2). Mass balance analysis 223 
showed 89.1 % (w/w) recovery for this extraction procedure. Insulin secretion by BRIN-BD11 pancreat-224 
ic beta cells was measured in the presence of glucose plus these fractions and the relative secretion with 225 
respect to WPH1 was determined (Table 2). Insulin secretion was significantly higher (P < 0.05) than 226 
that observed for WPH1 with one fraction (SPE X - unbound). A moderate insulinotropic activity was 227 
observed in the fraction SPE X - 40% ACN (Table 2). WPH1 (Supplementary data Fig. S3A), SPE X- 228 
unbound (Supplementary data Fig S3B) and SPE X- 40 % ACN (Supplementary data Fig. S3C) showed 229 
significantly different RP profiles. As expected, the RP profile of WPH1 showed more peptide peaks 230 
than SPE X - unbound or SPE X- 40 % ACN. Peptides in these samples elute according to their relative 231 
hydrophobicity. SPE X - unbound contains highly hydrophilic peptides which were not retained on the 232 
Strata-X cartridge eluting within the first 15 min of the chromatogram. For SPE X - 40 % ACN, most of 233 
the peptide peaks eluted around 20 min, indicating the hydrophobic nature of the peptides present in this 234 
fraction. 235 
AC was used in the same fashion as the Strata-X cartridges to fractionate WPH1. Recovery with AC 236 
was relatively low (36.9 % (w/w)), showing that a significant amount of WPH1 material remained tight-237 
ly bound to the AC. Insulin secretion by BRIN-BD11 cells was studied in the presence of the eight frac-238 
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tions obtained with the AC cartridge (Table 2). The relative extent of insulin secretion was always lower 239 
than that of WPH1 (relative insulin secretion < 1). The highest insulinotropic fraction was SPE AC - 5 240 
% ACN. The RP profile of SPE AC - 5 % ACN (Supplementary data Fig. S3D) showed very low inten-241 
sity peaks at 214 nm, which eluted within the first 5 min in agreement with the expected low hydropho-242 
bicity of this fraction. 243 
The RP profiles of fractions eluted with 40 % ACN with both adsorbents were compared (SPE X- 40 244 
% ACN – Supplementary data Fig. S3C and SPE AC - 40 % ACN – Supplementary data Fig. S3E). 245 
Both RP profiles showed very different peptide peaks with most peaks eluting before 20 min with AC in 246 
contrast with Strata-X where most peaks eluted after 20 min. This result suggested that AC allowed the 247 
production of fractions which were more hydrophilic in nature than Strata-X when eluted with the same 248 
ACN concentration. 249 
3.4. Semi-preparative RP-HPLC fractionation of WPH1 250 
WPH1 was injected on a semi-preparative C18 column and ten fractions F1 to F10 were collected. 251 
Semi-preparative RP-HPLC allowed collection of a range of hydrophilic and hydrophobic fractions 252 
(Fig. 1A). Hydrophilic peptides were eluted with HPLC grade water between 0 and 25 min correspond-253 
ing to fractions F1 to F4. Fractions F5 to F10 were collected during the course of the linear gradient of 254 
ACN which was started at 25 min. The ten fractions collected were tested for their insulinotropic activi-255 
ty. Activity in the fractions was expressed relative to the activity obtained with WPH1. F2 which was 256 
eluted with water (Fig. 1A) showed the highest relative insulinotropic activity compared to WPH1 (Fig. 257 
1B). The insulinotropic activity observed with WPH1 and F2 were not significantly different (P ≥ 0.05). 258 
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4. Discussion 259 
Comparison of the two starting substrates WP1 and WP2 using RP-HPLC analysis showed differ-260 
ences in their susceptibility to hydrolysis. This may be linked to differences in the extent of denaturation 261 
of the substrates leading to different susceptibility to enzymatic hydrolysis. The percentage denaturation 262 
of the proteins in the starting substrates (WP1 and WP2) was quantified by determining their solubility 263 
at pH 4.6 using RP-UPLC (Law & Leaver, 2000). The percentage denaturation for β-lactoglobulin was 264 
higher in WP2 (22.0 ± 1.0 % (w/w)) compared to WP1 (11.4 ± 1.1 % (w/w)) whereas denaturation of α-265 
lactalbumin was similar in both substrates (9.9 ± 1.3 and 8.0 ± 0.7 % (w/w) for WP1 and WP2, respec-266 
tively). The higher denaturation observed in WP2 may explain the lower level of intact whey proteins 267 
found in this hydrolysate. Processing parameters can cause protein unfolding resulting in better access 268 
by the enzyme to cleavage sites which were previously hidden within the folded protein structure 269 
(Hernández-Ledesma, Ramos, Recio, & Amigo, 2006). However, while there were differences in the 270 
RP-HPLC profiles of WPH1 and WPH2, the level of insulin secretion by BRIN-BD11 cells treated with 271 
these hydrolysates was not significantly different. In a previous study, we demonstrated that the insu-272 
linotropic properties of WPH1 when applied to BRIN BD11 pancreatic beta cells translated to an in vivo 273 
response with ob/ob mice (Gaudel et al., 2013). 274 
The influence of the hydrolysis process was investigated in order to determine differences between 275 
WP1 hydrolysates generated with pH control at pH 7.0 (WPH1) and without pH control (WPH3). A 276 
lower protein breakdown was seen in the RP-HPLC profile of WPH3 compared with WPH1 (Supple-277 
mentary data Fig. S1B and E). Alteration of pH affects the hydrolytic activity of enzymes thereby af-278 
fecting protein breakdown. A lower level of insulin secretion was obtained with WPH3 compared to 279 
WPH1 (Table 1), suggesting that bioactive amino acids or peptides were released to a lower extent 280 
without pH control during hydrolysis. The influence of hydrolysis pH on the bioactive properties of 281 
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milk protein hydrolysates has previously been reported in the literature. Van der Ven, Gruppen, de Bont 282 
& Voragen (2002) studied the influence of different processing parameters, including hydrolysis pH, 283 
during whey protein hydrolysis on angiotensin converting enzyme inhibitory (ACE) activity. They re-284 
ported an optimum value for hydrolysis pH (between 8 and 9) yielding a minimum IC50 for ACE inhibi-285 
tion. 286 
Free amino acid analysis of the different hydrolysates was carried out as per Mounier, Rea, 287 
O’Connor, Fitzgerald and Cogan (2007) showing higher levels of total free amino acids in WPH2 (12.7 288 
% (w/w)) and WPH1 (13.8 % (w/w)) compared to WPH3 (8.9 % (w/w)). Little difference in terms of 289 
free BCAA was seen between the 3 hydrolysates. However, the levels of Arg and Phe, which have been 290 
associated in the literature with an insulinotropic activity (Newsholme et al., 2006), were found in high-291 
er amounts in WPH1 and WPH2 (between 1.6 and 2.1 times more) compared to WHP3 (data not 292 
shown). It is anticipated that free amino acids and dipeptides would be bioavailable (Foltz et al., 2007; 293 
Morifuji et al., 2010) and therefore may reach pancreatic beta cells in vivo. It is interesting to note that 294 
the free amino acid level in WPH3 was decreased by 36 % compared to WPH1, which is of the same 295 
order of the decrease in insulin secretion (22 %) between WPH3 and WPH1. In this specific case, the 296 
level of free amino acid may be the main determinant for the insulinotropic properties of WPH3. Addi-297 
tion of base or acid to regulate pH during hydrolysis will result in modifications in the ionic content of 298 
hydrolysates (Aspmo, Horn, & Eijsink, 2005). Efforts are currently being made globally to reduce sodi-299 
um in foods in order to help minimise hypertension in the population (Campbell, Johnson, & Campbell, 300 
2012). Interestingly, in this regard, a significant level of bioactivity could be retained with WPH3 while 301 
reducing the sodium content by more than 70 % (w/w) compared to that in WPH1 (Table 1). 302 
The WPH1 hydrolysate was fractionated in order to better characterise the origin of the bioactive 303 
components within this sample. The recovery (89.1 % (w/w)) for WPH1 peptides eluted from the Strata-304 
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X SPE cartridge was of the same order as in the study of Herraiz and Casal (1995) and Nongonierma et 305 
al. (2013). The Strata-X- unbound fraction contained numerous peaks showing that several peptides had 306 
no affinity for the sorbent (Supplementary data Fig. S3B). Adsorption of peptides depends on their af-307 
finity for the sorbent. Therefore, peptides in the unbound fraction can be considered to be relatively hy-308 
drophilic while peptides eluting with higher ACN concentrations are relatively hydrophobic. WPH1 was 309 
composed of peptides having a wide range of hydrophobicities, which is consistent with the fact that 310 
different peptide peaks were eluted with increasing ACN concentration in the washing steps (Supple-311 
mentary data Fig. S3). Peptide recovery from AC SPE was relatively low (36.9 % (w/w)) compared to 312 
the recovery obtained using Strata-X SPE (89.1 % (w/w)). This value was of the same order as the re-313 
covery found with a lactoferrin hydrolysate (28.0 % (w/w)) (Nongonierma & FitzGerald, 2012). Irre-314 
versible adsorption of milk peptides on SPE adsorbents has been described previously (Herraiz & Casal, 315 
1995; Voirin et al., 1991). Differences in peptide binding to AC and Strata-X were seen, with binding to 316 
AC involving stronger hydrophobic interactions than binding to Strata-X. 317 
The unbound fraction obtained by Strata-X SPE was the only fraction giving a significantly higher (P 318 
< 0.05) insulin response than WPH1 (Table 2). It can be seen that the most potent fractions (SPE X - 319 
unbound, SPE AC - 5 % ACN and F2), obtained herein using the three fractionation techniques were 320 
relatively hydrophilic (Table 2 and Fig. 1A). Interestingly, analysis of the free amino acids present in 321 
the unbound material eluting from the Strata-X SPE - and in the 2 kDa permeate of WPH1 showed a 322 
significant enrichment in free amino acids, including BCAA, present in these fractions (Fig. 2). BCAA 323 
have been associated with insulinotropic effects (Dixon et al., 2003Dixon et al., 2003; Geerts et al., 324 
2011; Luhovyy et al., 2007; Manders et al., 2006a; Manders et al., 2006b; Newsholme et al., 2006) 325 
which may be responsible for the insulin secretion observed for these fractions. Twice the amount of 326 
free amino acids and BCAA’s were found in the Strata-X SPE and in the 2 kDa permeate compared to 327 
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WPH1. It would have been anticipated that the insulin secretion observed with these fractions would 328 
also double. However, there was only a modest increase in insulin secretion with both fractions. This 329 
suggests that free amino acids are not the only components of WPH1 which are responsible for the bio-330 
activity and that some peptides may also influence the insulinotropic properties of WPH1. This is fur-331 
ther reinforced by the fact that other hydrophobic fractions were also able to stimulate insulin release 332 
from BRIN-BD11 cells (Table 2).  333 
 334 
A possible explanation for the apparent inability to increase insulin secretion in comparison to the 335 
complete hydrolysate (WPH1) when using various fractions obtained by different fractionation strate-336 
gies may have been that BRIN-BD11 cells require specific mixtures of peptide combinations to promote 337 
insulin secretion. Overall our results herein suggest that the bioactivity observed within the WPH1 hy-338 
drolysate may arise from a mixture of free amino acids and peptides having a range of hydro-339 
philic/hydrophobic and molecular mass properties. 340 
Conclusion 341 
The role of free amino acids and bioactive peptides released during whey protein enzymatic hydroly-342 
sis on in vitro insulin secretion by pancreatic beta cells has been studied. Protein breakdown into pep-343 
tides and free amino acids is a prerequisite for the bioactive properties of the hydrolysate to be seen. The 344 
overall composition of the hydrolysate including its sodium, free amino acid, peptide and residual intact 345 
protein content may be modified by altering the hydrolysis conditions, e.g., by including, or excluding a 346 
pH adjustment step. This in turn was shown to directly affect the insulinotropic properties of the hydrol-347 
ysate. 348 
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All three fractionation procedures employed to enrich/isolate bioactive components showed that the 349 
most potent insulinotropic fractions obtained were hydrophilic. It was shown that these fractions were 350 
enriched in free amino acids and also contained hydrophilic peptides, which may both be responsible for 351 
the insulinotropic activity observed. However, other peptides with hydrophobic characteristics may also 352 
contribute to the insulinotropic properties of the whey protein hydrolysate. The results herein are of sig-353 
nificance to our understanding of the characteristics of insulinotropic amino acids and peptides within 354 
whey protein hydrolysates. 355 
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Table 1 Insulin secretion by BRIN-BD11 cells treated with unhydrolysed and hydrolysed whey protein 438 
substrates. 439 
 440 
 441 
Sample
1
 Insulin secretion (ng mg
-1
 protein)
2
 
WP1 0.90 ± 0.18
a
 
WPH1 5.62 ± 0.42
b
 
WP2 0.90 ± 0.23
a
 
WPH2 5.79 ± 0.35
b
 
WPH3 4.10 ± 0.55
c
 
 442 
1
 WP1 and WP2: unhydrolysed whey proteins, WPH1: WP1-derived hydrolysate manufactured with pH 443 
regulation at 7.0, WPH2: WP2-derived hydrolysate manufactured with pH regulation at 7.0 and WPH3: 444 
WP1-derived hydrolysate manufactured without pH regulation  445 
2
 Insulin secretion values are expressed in ng insulin released per mg of protein in the pancreatic BRIN-446 
BD11 cells. Average values ± SD of three replicates. Values with different superscript letters are signif-447 
icantly different (P < 0.05). 448 
 449 
450 
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Table 2 Relative amount of insulin secreted by BRIN-BD11 cells treated with whey protein-derived hy-451 
drolysate (WPH1) fractions obtained on elution from solid-phase extraction Strata-X (SPE X) and acti-452 
vated carbon (SPE AC) with different acetonitrile (ACN) concentrations. 453 
 454 
Sample
1
 Relative insulin secretion
2
 
 SPE X SPE AC 
WPH1 1.06 ± 0.13
b 
1.00 ± 0.16
a 
unbound 1.20 ± 0.14
a 
0.46 ± 0.03
b,c,d 
5 % ACN 0.21 ± 0.03
d 
0.70 ± 0.08
b 
10 % ACN 0.19 ± 0.01
e 
0.47 ± 0.09
b,c,d
 
15 % ACN 0.28 ± 0.07
e 
- 
20 % ACN 0.27 ± 0.05
e 
0.29 ± 0.00
c,d 
25 % ACN 0.26 ± 0.07
e 
- 
30 % ACN 0.19 ± 0.04
e 
0.25 ± 0.04
d 
35 % ACN 0.25 ± 0.06
e 
- 
40 % ACN 0.71 ± 0.09
c 
0.39 ± 0.14
c,d 
45 % ACN 0.56 ± 0.07
d 
- 
50 % ACN 0.20 ± 0.07
e 
0.44 ± 0.16
b,c,d
 
100 % ACN 0.66 ± 0.06
c,d 
0.23 ± 0.05
d 
 455 
1
SPE X : fractions obtained on elution from solid-phase extraction with Strata-X, SPE AC: fractions ob-456 
tained on elution from solid-phase extraction with activated carbon with different acetonitrile (ACN) 457 
concentrations 458 
2
Insulin secretion in BRIN-BD11 pancreatic beta cells relative to the secretion observed with WPH1. 459 
Average values ± SD of three replicates. In the same column, values with different superscript letters 460 
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were significantly different (P < 0.05).. The absolute value of insulin secretion obtained for WPH1 was 461 
of 5.51 ± 0.69 ng mg
-1
 protein. 462 
  
 
23 
Figure captions 463 
 464 
 465 
Fig. 1. Reverse-phase high pressure liquid chromatography (RP-HPLC) profile during the semi-466 
preparative separation of whey protein hydrolysate WPH1 (a) and relative insulin secretion in BRIN-467 
BD11 pancreatic beta cells observed with the semi-preparative RP-HPLC fractions of WPH1 (b). Val-468 
ues represent mean insulin secretion relative to the secretion observed withWPH1 ± SD of three repli-469 
cates, values with different superscript letters are significantly different (P < 0.05). The absolute value 470 
of insulin secretion obtained for WPH1 was of 2.52 ± 0.40 ng mg
-1
 protein. 471 
 472 
Fig. 2. Relative free amino acids amounts in the whey protein hydrolysate (WPH1) fraction unbound to 473 
the Strata X solid phase extraction cartridge (SPE X unbound) and its 2 kDa permeate compared to 474 
WPH1. Values represent mean free amino acid concentration relative to the whey protein hydrolysate 475 
WPH1 ± SD of three replicates. Ess: SPE X unbound and    : 2 kDa permeate. 476 
 477 
 478 
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Fig. S1. Reverse-phase ultra-performance liquid chromatography (UPLC) profiles of unhydrolysed 542 
whey proteins and whey protein hydrolysates. (a) WP1 (b) WPH1 (c) WP2 (d) WPH2 (e) WPH3. 1-543 
caseinomacropeptide, 2-bovine serum albumin, 3- α-lactalbumin, 4- β-lactoglobulin variants A and B. 544 
 545 
546 
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 555 
 556 
 557 
 558 
 559 
 560 
 561 
 562 
 563 
 564 
 565 
 566 
 567 
Fig. S2. Reverse-phase high pressure liquid chromatography (RP-HPLC) profiles of (a) whey protein 568 
substrate (WP1) (b) hydrolysate (WPH1) and (c) the 2 kDa permeate obtained by ultrafiltration of 569 
WPH1. 570 
 571 
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Fig. S3. Reverse-phase ultra-performance liquid chromatography (UPLC) profiles of the whey protein 598 
hydrolysate WPH1 and insulinotropic fractions obtained by solid-phase extraction (SPE). (a) WPH1 (b) 599 
fraction unbound to SPE Strata-X cartridge (c) fraction eluted from SPE Strata-X cartridge with 40 % 600 
ACN (d) fraction eluted from SPE activated carbon (AC) cartridge with 5 % ACN and (e) fraction elut-601 
ed SPE AC cartridge with 40 % ACN. 602 
 603 
